Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To evaluate the efficacy of Nilotinib in patients with unresectable or metastatic gastrointestinal stromal tumors. Efficacy is defined as the proportion of patients showing stable disease (SD), partial response (PR) or complete response (CR) during the first 6 months according to RECIST criteria.
Inclusion criteria
- metastatic or unresectable gastrointestinal stromal tumor